Skip to main content
. 2016 Jun 8;9:191–198. doi: 10.2147/IJGM.S100637

Table 4.

Echocardiographic findings of the study participants

Echo diagnosis All, n (%) Women (n=58) N (%) Men (n=44) N (%) Chi-square test P-value
LVH
 Yes 35 (34.3) 21 (36.2) 14 (31.8) 0.644
 No 67 (65.7) 37 (63.8) 30 (68.2)
RHD
 Yes 35 (34.3) 28 (48.3) 7 (15.9) 0.001*
 No 67 (65.7) 30 (51.7) 37 (84.1)
MS
 Yes 33 (32.3) 27 (46.6) 6 (13.6) <0.005*
 No 69 (67.7) 31 (53.4) 38 (86.4)
IHD
 Yes 11 (10.8) 5 (8.6) 6 (13.6) 0.419
 No 91 (89.2) 53 (91.4) 38 (86.4)
DCM
 Yes 14 (13.7) 6 (10.9) 8 (18.6) 0.280
 No 84 (82.4) 49 (89.1) 35 (81.4)
EF
 <35 7 (6.9) 4 (6.9) 3 (7.1) 0.962
 ≥35 93 (91.2) 54 (93.1) 39 (92.9)
E/A
 <0.7 27 (26.5) 16 (27.6) 11 (25.0) 0.769
 ≥0.7 75 (73.5) 42 (72.4) 33 (75.0)

Note:

*

P-value is significant (<0.05).

Abbreviations: LVH, left ventricular hypertrophy; RHD, rheumatic heart disease; MS, mitral stenosis; IHD, ischemic heart disease; DCM, dilated cardiomyopathy; EF, ejection fraction; E/A, ratio of the early (E) to late (A) ventricular filling velocities on echocardiography.